Abstract
Most prescribers and users of drugs are familiar with the cautions on drug use during the first trimester of pregnancy. These warnings were introduced after the thalidomide disaster in the early 1960s. However, limiting the exercise of caution to the first 3 months of pregnancy is both short sighted and effectively impossible. First, because chemicals can affect any stage of pre- or postnatal development, and second, because when a woman first learns that she is pregnant, the process of organogenesis has already long since begun, for example, the neural walls are closed. In the case of blood donations there exists a possibility that medicinal products, prescribed to donors or used by them as “over the counter” drugs can become available in the recipients of blood donations. Hence, it is interesting not only to focus on blood donation as such but also to discuss here in general the developmental toxicity of biologically active substances and especially medicinal products. Blood donation is in this context then a special route of exposure. This text will present the current state of knowledge about the (un)safety of the use of medicinal products, including those that might be presented by blood donation in pregnancy. One must realise that to my knowledge there exists no literature or other data showing such hazard and risk. However, biological active substances might be transferred by blood donation into recipients. Hence, it will be important to understand the main issues in the field of reproductive and developmental toxicology. A recent guide about the safety of use of drugs during pregnancy and lactation is edited by Schaefer [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Schaefer Chr. ed. Drugs during pregnancy and lactation, Amsterdam, Elsevier, 2001.
Chamberlain G. Organisation of antenatal care. BMJ 1991; 302: 647.
Warkany J, Nelson RC. Appearance of skeletal abnormalities in the offspring of rats retarded on a deficient diet. Science 1940; 92: 383–84.
Barker DJP. Mothers, babies and health in later life. Churchill Livingston, Edinburgh 1998, 2nd edition.
Hale F. Pigs born without eyeballs. J Hered 1933; 24: 105–06.
Gregg NM. Congenital cataract following German measles in mother. Trans Ophthalmol Soc Aust 1941; 3: 35–46.
Lenz W. Kindliche Fehlbildungen nach Medikament während der Gravidität? Dtsch Med Wochenschr 1961; 86: 2555–56.
Wilson JD. Embryotoxicity of drugs to man. In: Handbook of teratology, Vol. 1. Wilson JD, Frazer FC, eds.. New York, Plenum Press, 1977; 309–55.
Committee on Dev. Toxicol. NAS/NRC. Scientific Frontiers in Developmental Toxicology and Risk Assessment. National Research Council, Washington DC 2000; 10–25.
Loebstein R, Lalkin A, Koren G. Pharmacokinetic changes during pregnancy and their clinical relevance. Clin Pharmacokinet 1997; 33: 328–43.
Lander CM, Smith MT, Chalk JB et al. Bioavailability in pharmacokinetics of phenytoin during pregnancy. Eur J Clin Pharmacol 1984; 27: 105–10.
Juchau MR. Bioactivation in chemical teratogenesis. Ann Rev Pharmacol Toxicol 1989; 29: 165–87.
Schardein JL. Chemically induced birth defects. New York, Marcel Dekker, 2000, 4th edition.
Enders G. Infektionen und Impfungen in der Schwangerschaft. München, Urban & Schwarzenberg, 1991, 2nd edition.
Nelson K, Holmes LB. Malformations due to presumed spontaneous mutations in newborn infants. N Engl J Med 1989; 320: 19–23.
Shepard TH. Letter: “proof” of teratogenicity. Teratology 1994; 50: 97.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Peters, P.W.J. (2002). Blood Donation; a Risk for Prenatal Developmental Toxicity?. In: Sibinga, C.T.S., Dodd, R.Y. (eds) Transmissible Diseases and Blood Transfusion. Developments in Hematology and Immunology, vol 37. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6869-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-4757-6869-5_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-5233-2
Online ISBN: 978-1-4757-6869-5
eBook Packages: Springer Book Archive